Obsidian Therapeutics
OBX · NASDAQ
$13.25+$1.31 (+10.97%)TodayMarket closed ·
Prev close $11.94
Who owns OBX
Largest institutional holders, from their latest 13F filings
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| T. Rowe Price Innovation Leaders ETF | 604 | — |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of OBX in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Jagasia Madan | Award | 37.65K | — |
| Norkunas Matthew | Award | 37.65K | — |
| ROSS ROBERT W. | Award | 37.65K | — |
| Hagen Heidi | Award | 37.65K | — |
| Fardis Maria | Award | 37.65K | — |
| Barrett Peter | Award | 37.65K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 884.53K
- Days to cover
- 1.00
- % of shares outstanding
- —
- Average daily volume
- 1.02M
- Change since last report
- +249.5%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.